Browsing by Author "Cengiz, Mustafa"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Publication Cerebral hydatid cyst with intraventricular extension: A case report(Oxford Univ Press, 2019-12-01) Cingöz, Mehmet; Olmaz, Burak; Akdoğan, Emin; Cengiz, Mustafa; Kandemirli, Sedat Giray; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Radyoloji Anabilim Dalı.; A-1409-2017Intracranial hydatid cyst is a rare entity, comprising about 2-3% of all hydatid cysts. Similarly, intracranial hydatid cysts account for 1-2% of all intracranial lesions. Clinical symptoms are generally nonspecific and patients usually present with symptoms of increased intracranial pressure. Cerebral hydatid cysts can be either primary or secondary to systemic hydatid disease. Primary cerebral hydatid cysts are usually solitary, unilocular with an intraparenchymal location. Intraventricular extension of hydatid cysts account for a limited percentage of all cerebral hydatid cysts with limited number of cases reported. Herein, we present the imaging and surgical findings of a primary cerebral hydatid cyst that is located in frontal lobe parenchyma with partial extension into the ventricular system.Item Zoledronic acid concurrent with either high-or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: A phase IV randomized clinical study(Springer, 2010-06) Atahan, Lale; Yıldız, Ferah; Cengiz, Mustafa; Kaplan, Bünyamin; Özkan, Metin; Yazıcı, Gözde; Gündoğ, Mete; Haydaroğlu, Ayfer; Korcum, Aylin Fidan; Şengöz, Meriç; Dinçer, Maktav; Akmansu, Müge; Hayran, Mutlu; Engin, Kayıhan; Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı.; 6701768798In this prospective study, the efficacy and safety of radiotherapy combined with zoledronic acid was evaluated. Breast cancer patients with painful bone metastases were randomized to either high- or reduced-dose radiotherapy. All patients received zoledronic acid (4 mg) every 28 days from the beginning of radiotherapy. Analgesic and pain scores in addition to visual analog score (VAS) for treatment satisfaction and whole-body bone scintigraphy were evaluated. No significant differences could be found in analgesic or pain scores and bone scintigraphy results between the groups. Our results suggest that reduced-dose radiotherapy produces similar response rates and response durations when used concomitantly with zoledronic acid.